Strata Critical Medical, Inc.
SRTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -1.46 | 0.23 | -0.02 |
| FCF Yield | -9.76% | -1.77% | -1.56% | -2.01% |
| EV / EBITDA | -50.04 | -87.39 | -32.68 | -48.01 |
| Quality | ||||
| ROIC | 10.86% | -2.09% | -3.25% | -3.49% |
| Gross Margin | 23.56% | 25.05% | 22.06% | 23.16% |
| Cash Conversion Ratio | 3.30 | 1.13 | 1.30 | -0.00 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.96% | 10.19% | 15.14% | 19.39% |
| Free Cash Flow Growth | -603.40% | -70.50% | 50.00% | -90.74% |
| Safety | ||||
| Net Debt / EBITDA | 2.42 | 15.71 | 4.38 | 1.32 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 3.52 | 12.61 | 36.67 | 35.75 |